The role of LATS kinases in regulation of CDK4/6 in ovarian cancer.

被引:0
|
作者
Saini, Siddharth [1 ]
Sesay, Fatmata [1 ]
Litovchick, Larisa [1 ]
机构
[1] Virginia Commonwealth Univ, Richmond, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B49
引用
收藏
页码:109 / 109
页数:1
相关论文
共 50 条
  • [1] CDK4/6 inhibition as maintenance therapy in ovarian cancer.
    Iyengar, Mangala
    Coffman, Lan
    Buckanovich, Ronald
    CLINICAL CANCER RESEARCH, 2016, 22
  • [2] PROTACs suppression of CDK4/6, crucial kinases for cell cycle regulation in cancer
    Zhao, Bosheng
    Burgess, Kevin
    CHEMICAL COMMUNICATIONS, 2019, 55 (18) : 2704 - 2707
  • [3] The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer
    Liu, Chen
    Huang, Yuhan
    Cui, Yaoyuan
    Zhou, Jun
    Qin, Xu
    Zhang, Li
    Li, Xi
    Li, Yuan
    Guo, Ensong
    Yang, Bin
    Fan, Junpeng
    Li, Xiong
    Fu, Yu
    Liu, Si
    Hu, Dianxing
    Xiao, Rourou
    Wang, Zizhuo
    Dou, Yingyu
    Wang, Wei
    Li, Wenting
    Yang, Xiaohang
    Liu, Jingbo
    Peng, Wenju
    Qin, Tianyu
    You, Lixin
    Lu, Funian
    Sun, Chaoyang
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [4] CDK4 and CDK6 kinases: From basic science to cancer therapy
    Fassl, Anne
    Geng, Yan
    Sicinski, Piotr
    SCIENCE, 2022, 375 (6577) : 158 - +
  • [5] Cardiac complications of CDK4/6 inhibitors for breast cancer.
    Master, Samip R.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [7] The role of targeting CDK4/6 in cancer immunotherapy
    Mengyu Sun
    Lin Dong
    Yu Wang
    Chao Liu
    Jiang Du
    Bo Wang
    Bofan Xing
    Xiaofeng Yao
    Yu Ren
    Xuan Zhou
    Holistic Integrative Oncology, 3 (1):
  • [8] The Role of CDK4/6 Inhibition in Breast Cancer
    Murphy, Conleth G.
    Dickler, Maura N.
    ONCOLOGIST, 2015, 20 (05): : 483 - U49
  • [9] The Role of CDK4/6 Inhibitors in Breast Cancer
    Conleth G. Murphy
    Current Treatment Options in Oncology, 2019, 20
  • [10] The role of CDK4/6 inhibitors in early breast cancer
    Gil-Gil, Miguel
    Alba, Emilio
    Gavila, Joaquin
    de la Haba-Rodriguez, Juan
    Ciruelos, Eva
    Tolosa, Pablo
    Candini, Daniele
    Llombart-Cussac, Antonio
    BREAST, 2021, 58 : 160 - 169